Spirovant
  • Home
  • Science
    • Technology
    • Pipeline
  • About Us
  • Newsroom
    • Press Releases
    • Publications
  • Careers
  • Contact Us
Menu
  • Home
  • Science
    • Technology
    • Pipeline
  • About Us
  • Newsroom
    • Press Releases
    • Publications
  • Careers
  • Contact Us

Links

<a href="https://www.mdpi.com/2073-4425/10/3/218"> Lentiviral Vectors for the Treatment and Prevention of Cystic Fibrosis Lung Disease </a>

<a href="https://pubmed.ncbi.nlm.nih.gov/15564131/">Dual therapeutic utility of proteasome modulating agents for pharmaco-gene therapy of the cystic fibrosis airway</a>

<a href="https://pubmed.ncbi.nlm.nih.gov/14990705/">Distinct classes of proteasome-modulating agents cooperatively augment recombinant adeno-associated virus type 2 and type 5-mediated transduction from the apical surfaces of human airway epithelia</a>

<a href="https://pubmed.ncbi.nlm.nih.gov/25763813/">Optimization of Recombinant Adeno-Associated Virus-Mediated Expression for Large Transgenes, Using a Synthetic Promoter and Tandem Array Enhancers </a>

<a href="https://pubmed.ncbi.nlm.nih.gov/19237554/">Directed evolution of adeno-associated virus to an infectious respiratory virus</a>

<a href="https://spirovant.com/wp-content/uploads/2022/03/NACFC-SP-101_POSTER_Master-9-22-2181-Read-Only-1.pdf">Katherine Excoffon: Delivery of SP-101 restores CFTR function in human CF airway epithelial cultures and drives hCFTRΔR transgene expression in the airways of ferrets. North American Cystic Fibrosis Conference 2021. – Poster</a>

Spirovant Sciences, Inc.
3675 Market Street, Suite 900 Philadelphia, PA 19104
info@spirovant.com
(267) 244-8206

Twitter Linkedin
  • Terms of Use
  • Privacy Policy
Menu
  • Terms of Use
  • Privacy Policy

© Copyright 2016-2022 Spirovant Sciences Inc. All rights reserved.